Drugmakers with White House pricing deals may skirt new Medicare demosnews2025-12-23T18:57:02+00:00December 23rd, 2025|Endpoints News|
Gilead’s herpes deal; FDA approvals for Boehringer, Rochenews2025-12-23T14:46:06+00:00December 23rd, 2025|Endpoints News|
F.D.A. Approves Wegovy Weight-Loss Pillnews2025-12-23T14:37:51+00:00December 23rd, 2025|The New York Times|
Labcorp backs Cellens in developing physics test aimed at bladder cancernews2025-12-23T14:00:11+00:00December 23rd, 2025|Endpoints News|
OUTLOOK ’26: Europe bio-naphtha supply remains tight on fuel mandatesnews2025-12-23T14:00:00+00:00December 23rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Maire sells 7.9% stake in Nextchem subsidiary to Azzurra Capitalnews2025-12-23T13:53:00+00:00December 23rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Plant status: Saudi Arabia’s SEPC schedules HDPE, LDPE turnarounds for late Januarynews2025-12-23T13:30:00+00:00December 23rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsynews2025-12-23T13:28:14+00:00December 23rd, 2025|Endpoints News|
